Michel Ducreux
Université Paris-Saclay(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Gastric Cancer Management and Outcomes, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer(2011)7,636 cited
- → Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma(2020)6,907 cited
- → ESMO consensus guidelines for the management of patients with metastatic colorectal cancer(2016)3,389 cited
- → KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer(2006)2,215 cited
- → Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203(2006)1,727 cited
- → Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma(2021)1,515 cited